{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T23:02:56Z","timestamp":1784502176581,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":63,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-53296-8","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T19:34:37Z","timestamp":1779132877000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of pyrazinamide resistance in Mycobacterium tuberculosis with mutations in rpoB, katG, and inhA genes"],"prefix":"10.1038","volume":"16","author":[{"given":"Kartiki","family":"Srivastava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajniti","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sada Nand","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shampa","family":"Anupurba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"issue":"26","key":"53296_CR1","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1056\/NEJMc1613123","volume":"375","author":"AH Diacon","year":"2016","unstructured":"Diacon, A. H., Van Baelen, B. & Theeuwes, M. More on treatment outcomes in multidrug-resistant tuberculosis. N Engl. J. Med. 375 (26), 2609\u20132610 (2016).","journal-title":"N Engl. J. Med."},{"issue":"9","key":"53296_CR2","doi-asserted-by":"publisher","first-page":"e6914","DOI":"10.1371\/journal.pone.0006914","volume":"4","author":"JC Johnston","year":"2009","unstructured":"Johnston, J. C., Shahidi, N. C., Sadatsafavi, M. & Fitzgerald, J. M. Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis. PLoS One. 4 (9), e6914 (2009).","journal-title":"PLoS One"},{"issue":"10150","key":"53296_CR3","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/S0140-6736(18)31644-1","volume":"392","author":"N Ahmad","year":"2018","unstructured":"Ahmad, N. et al. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis. Lancet 392 (10150), 821\u2013834 (2018).","journal-title":"Lancet"},{"key":"53296_CR4","unstructured":"World Health Organization. Global tuberculosis report 2019. Geneva: World Health Organization. (2019). Available from: https:\/\/www.who.int\/publications-detail\/global-tuberculosis-report-2019"},{"key":"53296_CR5","unstructured":"World Health Organization. WHO consolidated guidelines on drug-resistant tuberculosis treatment. Geneva: World Health Organization. (2019). Available from: https:\/\/www.who.int\/publications\/i\/item\/9789241550529"},{"issue":"1","key":"53296_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.advms.2015.09.007","volume":"61","author":"M Njire","year":"2016","unstructured":"Njire, M. et al. Pyrazinamide resistance in Mycobacterium tuberculosis: Review and update. Adv. Med. Sci. 61 (1), 63\u201371 (2016).","journal-title":"Adv. Med. Sci."},{"issue":"11","key":"53296_CR7","first-page":"1320","volume":"13","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y. & Yew, W. W. Mechanisms of drug resistance in Mycobacterium tuberculosis. Int. J. Tuberc Lung Dis. 13 (11), 1320\u20131330 (2019).","journal-title":"Int. J. Tuberc Lung Dis."},{"issue":"10","key":"53296_CR8","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.5588\/ijtld.14.0100","volume":"18","author":"KJ Aung","year":"2014","unstructured":"Aung, K. J. et al. Successful \u20189-month Bangladesh regimen\u2019 for multidrug-resistant tuberculosis among over 500 consecutive patients. Int. J. Tuberc Lung Dis. 18 (10), 1180\u20131187 (2014).","journal-title":"Int. J. Tuberc Lung Dis."},{"issue":"10","key":"53296_CR9","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1093\/cid\/ciu619","volume":"59","author":"ML Bastos","year":"2014","unstructured":"Bastos, M. L. et al. Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first- and second-line drugs: an individual patient data meta-analysis. Clin. Infect. Dis. 59 (10), 1364\u20131374 (2014).","journal-title":"Clin. Infect. Dis."},{"issue":"7","key":"53296_CR10","doi-asserted-by":"publisher","first-page":"e0133869","DOI":"10.1371\/journal.pone.0133869","volume":"10","author":"MG Whitfield","year":"2015","unstructured":"Whitfield, M. G. et al. A global perspective on pyrazinamide resistance: systematic review and meta-analysis. PLoS One. 10 (7), e0133869 (2015).","journal-title":"PLoS One"},{"issue":"1","key":"53296_CR11","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1186\/s12879-017-2594-3","volume":"17","author":"S Sengstake","year":"2017","unstructured":"Sengstake, S. et al. Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in Georgia. BMC Infect. Dis. 17 (1), 491 (2017).","journal-title":"BMC Infect. Dis."},{"issue":"5","key":"53296_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0232543","volume":"15","author":"R Naluyange","year":"2020","unstructured":"Naluyange, R. et al. High prevalence of phenotypic pyrazinamide resistance and its association with pncA gene mutations in Mycobacterium tuberculosis isolates from Uganda. PLoS One. 15 (5), 1\u20138 (2020).","journal-title":"PLoS One"},{"issue":"9","key":"53296_CR13","doi-asserted-by":"publisher","first-page":"5267","DOI":"10.1128\/AAC.00204-15","volume":"59","author":"SM Ramirez-Busby","year":"2015","unstructured":"Ramirez-Busby, S. M. & Valafar, F. Systematic review of mutations in pyrazinamidase associated with pyrazinamide resistance in Mycobacterium tuberculosis clinical isolates. Antimicrob. Agents Chemother. 59 (9), 5267\u20135277 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"53296_CR14","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1128\/AAC.41.3.540","volume":"41","author":"A Scorpio","year":"1997","unstructured":"Scorpio, A. et al. Characterization of pncA mutations in pyrazinamide resistant Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 41, 540\u2013543 (1997).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"10","key":"53296_CR15","doi-asserted-by":"publisher","first-page":"5186","DOI":"10.1128\/AAC.05385-11","volume":"56","author":"K Stoffels","year":"2015","unstructured":"Stoffels, K., Mathys, V., Fauville-Dufaux, M., Wintjens, R. & Bifani, P. Systematic analysis of pyrazinamide-resistant spontaneous mutants and clinical isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 56 (10), 5186\u20135193 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"53296_CR16","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.5588\/ijtld.15.0167","volume":"19","author":"N Ahmad","year":"2015","unstructured":"Ahmad, N. et al. Management and treatment outcomes of MDR-TB: results from a setting with high rates of drug resistance. Int. J. Tuberc Lung Dis. 19 (9), 1109\u20131114 (2015).","journal-title":"Int. J. Tuberc Lung Dis."},{"issue":"10","key":"53296_CR17","doi-asserted-by":"publisher","first-page":"4499","DOI":"10.1128\/AAC.00630-11","volume":"55","author":"KC Chang","year":"2011","unstructured":"Chang, K. C., Yew, W. W. & Zhang, Y. Pyrazinamide susceptibility testing in Mycobacterium tuberculosis: a systematic review with meta-analyses. Antimicrob. Agents Chemother. 55 (10), 4499\u20134505 (2011).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"12","key":"53296_CR18","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.5588\/ijtld.15.0274","volume":"19","author":"G Gunther","year":"2015","unstructured":"Gunther, G. et al. Beyond multidrug-resistant tuberculosis in Europe: a TBNET study. Int. J. Tuberc Lung Dis. 19 (12), 1524\u20131527 (2015).","journal-title":"Int. J. Tuberc Lung Dis."},{"issue":"34","key":"53296_CR19","first-page":"100411","volume":"25","author":"G Balay","year":"2023","unstructured":"Balay, G. et al. Resistance to pyrazinamide in Mycobacterium tuberculosis complex isolates from previously treated tuberculosis cases in Southwestern Oromia. Ethiopia J Clin. Tuberc Other Mycobact. Dis. 25 (34), 100411 (2023).","journal-title":"Ethiopia J Clin. Tuberc Other Mycobact. Dis"},{"key":"53296_CR20","unstructured":"Cepheid, C. A. Cepheid; Report No.: 302\u20135776 Rev. D. (2023). Nov Available from: https:\/\/infomine.cepheid.com"},{"key":"53296_CR21","doi-asserted-by":"publisher","first-page":"e02506","DOI":"10.1128\/spectrum.02506-24","volume":"13","author":"K Srivastava","year":"2025","unstructured":"Srivastava, K., Singh, V., Raikwar, V. K. & Anupurba, S. Diagnostic accuracy of direct drug susceptibility testing of second-line antitubercular drugs. Microbiol. Spectr. 13, e02506\u2013e02524 (2025).","journal-title":"Microbiol. Spectr."},{"issue":"1","key":"53296_CR22","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12941-021-00463-6","volume":"20","author":"K Singh","year":"2021","unstructured":"Singh, K. et al. Direct detection of resistance to fluoroquinolones\/SLIDs in sputum specimen by GenoType MTBDRsl v.2.0 assay A study from Eastern Uttar Pradesh, India. Ann. Clin. Microbiol. Antimicrob. 20 (1), 56 (2021).","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"issue":"7","key":"53296_CR23","doi-asserted-by":"publisher","first-page":"e0159651","DOI":"10.1371\/journal.pone.0159651","volume":"11","author":"R Kumari","year":"2016","unstructured":"Kumari, R. et al. Rapid Screening of MDR-TB in Cases of Extra Pulmonary Tuberculosis Using Geno Type MTBDRplus. PLoS One. 11 (7), e0159651 (2016).","journal-title":"PLoS One"},{"key":"53296_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1756-0500-4-79","volume":"4","author":"VG Kumar","year":"2011","unstructured":"Kumar, V. G., Urs, T. A. & Ranganath, R. R. MPT 64 Antigen detection for Rapid confirmation of M. tuberculosis isolates. BMC Res. Notes. 4, 79 (2011).","journal-title":"BMC Res. Notes"},{"issue":"8","key":"53296_CR25","doi-asserted-by":"publisher","first-page":"e00145","DOI":"10.1128\/JCM.00145-19","volume":"57","author":"KK Tam","year":"2019","unstructured":"Tam, K. K. et al. Direct Detection of Pyrazinamide Resistance in Mycobacterium tuberculosis by Use of pncA PCR Sequencing. J. Clin. Microbiol. 57 (8), e00145\u2013e00119 (2019).","journal-title":"J. Clin. Microbiol."},{"issue":"1","key":"53296_CR26","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1186\/s12879-021-06306-1","volume":"21","author":"Y Che","year":"2021","unstructured":"Che, Y. et al. Phenotypic and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Ningbo, China. BMC Infect. Dis. 21 (1), 605 (2021).","journal-title":"BMC Infect. Dis."},{"key":"53296_CR27","first-page":"1","volume":"10","author":"J Onmalung","year":"2010","unstructured":"Onmalung, J., Prammananan, T., Leechawengwongs, M. & Chaiprasert, A. Surveillance of pyrazinamide susceptibility among multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand. BMC Microbiol. 10, 1\u20136 (2010).","journal-title":"BMC Microbiol."},{"issue":"10","key":"53296_CR28","doi-asserted-by":"publisher","first-page":"e0187211","DOI":"10.1371\/journal.pone.0187211","volume":"12","author":"JC Ngabonziza","year":"2017","unstructured":"Ngabonziza, J. C. et al. Half of rifampicin-resistant Mycobacterium tuberculosis complex isolated from tuberculosis patients in Sub-Saharan Africa have concomitant resistance to pyrazinamide. PLoS ONE. 12 (10), e0187211 (2017).","journal-title":"PLoS ONE"},{"key":"53296_CR29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.tube.2016.02.008","volume":"98","author":"P Xu","year":"2016","unstructured":"Xu, P. et al. Prevalence and transmission of pyrazinamide resistant Mycobacterium tuberculosis in China. Tuberculosis 98, 56\u201361 (2016).","journal-title":"Tuberculosis"},{"key":"53296_CR30","doi-asserted-by":"publisher","first-page":"100411","DOI":"10.1016\/j.jctube.2023.100411","volume":"34","author":"G Balay","year":"2023","unstructured":"Balay, G. et al. Resistance to pyrazinamide in Mycobacterium tuberculosis complex isolates from previously treated tuberculosis cases in Southwestern Oromia, Ethiopia. J. Clin. Tuberc Other Mycobact. Dis. 34, 100411 (2023).","journal-title":"J. Clin. Tuberc Other Mycobact. Dis."},{"issue":"4","key":"53296_CR31","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S2213-2600(17)30079-6","volume":"5","author":"K Dheda","year":"2017","unstructured":"Dheda, K. et al. The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug resistant, and incurable tuberculosis. Lancet Respiratory Med. 5 (4), 291\u2013360 (2017).","journal-title":"Lancet Respiratory Med."},{"issue":"99","key":"53296_CR32","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.tube.2016.05.003","volume":"1","author":"MG Whitfield","year":"2016","unstructured":"Whitfield, M. G. et al. Prevalence of pyrazinamide resistance across the spectrum of drug resistant phenotypes of Mycobacterium tuberculosis. Tuberculosis 1 (99), 128\u2013130 (2016).","journal-title":"Tuberculosis"},{"issue":"1","key":"53296_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jgar.2014.10.002","volume":"3","author":"G Ramasubban","year":"2015","unstructured":"Ramasubban, G. et al. Detection of novel and reported mutations in the rpoB, katG and inhA genes in multidrug-resistant tuberculosis isolates: A hospital-based study. J. Glob Antimicrob. Resist. 3 (1), 1\u20134 (2015).","journal-title":"J. Glob Antimicrob. Resist."},{"issue":"5","key":"53296_CR34","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.eimc.2018.09.002","volume":"37","author":"R Zenteno-Cuevas","year":"2019","unstructured":"Zenteno-Cuevas, R., Cuevas-C\u00f3rdoba, B., Parissi-Crivelli, A. & rpoB katG and inhA mutations in multi-drug resistant strains of Mycobacterium tuberculosis clinical isolates from southeast Mexico. Enferm Infecc Microbiol. Clin. (Engl Ed). 37 (5), 307\u2013313 (2019).","journal-title":"Enferm Infecc Microbiol. Clin. (Engl Ed)"},{"issue":"12","key":"53296_CR35","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.3390\/antibiotics11121733","volume":"11","author":"S Saikaew","year":"2022","unstructured":"Saikaew, S. et al. Genotypic Distribution and the Epidemiology of Multidrug Resistant Tuberculosis in Upper Northern Thailand. Antibiotics 11 (12), 1733 (2022).","journal-title":"Antibiotics"},{"issue":"6","key":"53296_CR36","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1128\/JCM.02532-16","volume":"55","author":"J Werngren","year":"2017","unstructured":"Werngren, J., Alm, E. & Mansj\u00f6, M. Non-pncA Gene-Mutated but Pyrazinamide-Resistant Mycobacterium tuberculosis: Why Is That? J. Clin. Microbiol. 55 (6), 1920\u20131927 (2017).","journal-title":"J. Clin. Microbiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53296-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53296-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53296-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T22:41:00Z","timestamp":1784500860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53296-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["53296"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-53296-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"24 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"22578"}}